Are patients in clinical trials representative of the general population? Dose intensity and toxicities associated with FE100C-D chemotherapy in a non-trial population of node positive breast cancer patients compared with PACS-01 trial group

✍ Scribed by Judith Fraser; Nicola Steele; Aysha Al Zaman; Alison Yule

• Book ID: 116430578
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 146 KB
• Volume: 47
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/j.ejca.2010.10.001